Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Nishant Shah

Preventive Cardiology · Duke Hospital

View

Dr. Amit Khera

Preventive Cardiology · UT Southwestern

View

Dr. Martha Gulati

Preventive Cardiology · Houston Methodist

View

Dr. Pradeep Natarajan

Preventive Cardiology · MGH

View

Dr. Christopher Cannon

Preventive Cardiology · BWH

View

Dr. Nicholas Marston

Preventive Cardiology · BWH

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JRDr. James Revkin

    Dr. James Revkin

    Cardiology · Preventive Cardiology
    Mass General Brigham
    jamesr

    Research

    A Phase Ib First-In-Patient Study Assessing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ponsegromab in Participants with Cancer and Cachexia

    2024

    Via Clinical Cancer Research

    Research

    Phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia: PROACC-1 study design

    2024

    Via Journal of cachexia, sarcopenia and muscle

    Research

    Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: A systematic literature review and meta-analysis

    2024

    Via Journal of cachexia, sarcopenia and muscle

    Research

    The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review

    2024

    Via Journal of cachexia, sarcopenia and muscle

    Research

    Association between growth differentiation factor-15 and adverse outcomes among patients with heart failure: A systematic literature review

    2024

    Via Heliyon

    Research

    ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor

    2022

    Via American Heart Journal

    Research

    Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week

    2021

    Via Journal of the American College of Cardiology

    Research

    Defining the path ahead for NOAC use in the pediatric population: A Cardiac Safety Research Consortium Think Tank

    2020

    Via American Heart Journal

    Research

    Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab

    2018

    Via Journal of Clinical Lipidology

    Research

    Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab

    2017

    Via The New England Journal of Medicine

    Research

    Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency

    2016

    Via European Journal of Heart Failure

    Research

    Rate of change in carotid intima-media thickness and vascular events: meta-analyses can not solve all the issues. A point of view

    2012

    Via Journal of Hypertension

    Research

    Surrogate endpoints in randomized cardiovascular clinical trials

    2010

    Via Fundamental & Clinical Pharmacology

    Research

    Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

    2017

    Via The New England Journal of Medicine